Trastuzumab MMAE

Trastuzumab MMAE is an antibody-drug conjugate (ADC) composed of an anti-HER2 antibody, conjugated to Monomethyl Auristatin E (MMAE), via a Mc linker. Trastuzumab MMAE has the potential for use in research of solid tumors mainly in HER2-positive breast cancer.
Supplier Alfa Cytology
Product # BE0005
Pricing 1 mg, Bulk Size, inquire
Feedback